Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q3 2019 Earnings

14NovExpected
Q4 2018
Q1 2019
Q2 2019
Q3 2019
-0.66
-0.17
0.32
0.81

Details

Expected EPS
N/A
Actual EPS
-0.66
Surprise EPS
-0.66
Surprise Percent
+∞%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -0.66 per share for Q3 2019.

0 Comments

Share your thoughts